Key stats
Market capitalization
404.147MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.62USD
About Quanterix Corporation
ISIN
US74766Q1013
Sector
Health Technology
Industry
Medical Specialties
Website
quanterix.com
CEO
Masoud Toloue
Headquarters
Billerica
Employees
370
Founded
2007
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
QTRX ( Quanterix Corporation) - Bullish QuarterQuanterix Corporation
Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvett
$QTRX Swing trade idea this stock has been in a up trend every time it pulls back to the 50 day SMA it has broke and headed north this stock has pulled back to the up trend line if it breaks the down trend line and closes above this could push up to 62.48 area at its 1.618 fib ext. with a stop of a break below the 50 day
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0